GNOM - Global X Funds Global X Genomics & Biotechnology ETF -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Global X Funds Global X Genomics & Biotechnology ETF
IPO Date: April 5, 2019
Sector: Healthcare
Industry: Biotech
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.31 | 1.58%
Avg Daily Range (30 D): $1.16 | 1.85%
Avg Daily Range (90 D): $0.95 | 1.71%
Institutional Daily Volume
Avg Daily Volume: .07M
Avg Daily Volume (30 D): .03M
Avg Daily Volume (90 D): .02M
Trade Size
Avg Trade Size (Sh.): 253
Avg Trade Size (Sh.) (30 D): 134
Avg Trade Size (Sh.) (90 D): 145
Institutional Trades
Total Institutional Trades: 181
Avg Institutional Trade: $2.8M
Avg Institutional Trade (30 D): $2.37M
Avg Institutional Trade (90 D): $2M
Avg Institutional Trade Volume: .22M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $.85M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 62.88K
 
News
Jun 28, 2023 @ 9:42 PM
Top ETFs Tracking CRISPR Gene Editing
Source: newsfeedback@fool.com (Keith Speights)
Jan 25, 2023 @ 6:55 PM
Will 2023 be the Year of Cathie Wood ETFs?
Source: Sanghamitra Saha
Jul 8, 2022 @ 12:00 PM
Pharma & Biotech ETFs at One-Month High: Here's Wh...
Source: Sanghamitra Saha
Dec 29, 2021 @ 10:08 PM
Is ARK's Stellar Run Over? 5 ETF Themes to Follow ...
Source: Sanghamitra Saha
Oct 25, 2021 @ 4:20 AM
Weekly Market Pulse: Inflation Scare
Source: Joseph Calhoun
Financials
  TTM Q3 2012 Q2 2012
Basic EPS
Diluted EPS
Revenue $22.35M $7.28M $8.69M
Gross Profit $-5.73M $.05M $.57M
Net Income / Loss $-79.37M $-17.99M $-18.83M
Operating Income / Loss $-76.43M $-17.32M $-18.09M
Cost of Revenue $28.07M $7.23M $8.12M
Net Cash Flow $-30.2M $-4.54M $-7.86M
PE Ratio    
Splits
Sep 02, 2025 1:4